EUVIMEDDescoperă EUVIMED
EUVIMED · CrossrefJournal

Journal of Sickle Cell Disease

ISSN 3029-0473 · Oxford University Press (OUP)

Latest articles

  1. Efficacy and safety of osivelotor in participants with sickle cell disease in a 12-week, phase 2, multicenter, open-label, dose-finding trial and extension study

    Santosh L Saraf, Shehu U Abdullahi, Adeseye M Akinsete, Foluke A Fasola, Modupe Idowu, Sharon Pennington, Sheinei S Alan, Marshall Patrick Stagg, Earl J Fields, David R Archer, Aliya Zaidi, Patrick Hines, Yuvika Paliwal, Denis Rybin, Eric I Zimmerman, Adeyemi Adenola, Mira Patel Pochron, Eleanor A Lisbon, Geoffrey Allen

    Published: 2026-06-01DOI: 10.1093/jscdis/yoag020.001

  2. Secretory phospholipase A2 (sPLA2) during vaso-occlusive pain episodes (VOE) and acute chest syndrome (ACS) in sickle cell disease (SCD): results from a prospective multi-center randomized controlled trial (RCT)

    Noor Alzraikat, Rawan Korman, Fahd Ahmad, Gladstone Airewele, Bolanle Akinsola, Nitya Bakshi, David C Brousseau, Kathleen Brown, Andrew D Campbell, T Charles Casper, Todd P Chang, Corrie E Chumpitazi, Daniel Cohen, Keli D Coleman, Andrea T Cruz, Carlton Dampier, Christopher Denton, Angela Ellison, Melanie E Fields, Hailey Jensen, Elizabeth S Klings, Dunia Hatabah, Sara Leibovich, Derek Meyer, Seth Otto, Chris A Rees, Allison Remiker, Nidhi V Singh, Alexis A Thompson, Elliott Vichinsky, Anthony Villella, Bridget Wynn, Claudia R Morris

    Published: 2026-06-01DOI: 10.1093/jscdis/yoag020.010

  3. Using Electronic-Medical Records to Facilitate Transition From Pediatric to Adult Hematology for Sickle Cell Disease

    Venée N Tubman, Abdullah Kutlar, Albert C Hergenroeder, Alexis A Thompson, Constance M Wiemann, Oluwaseun Olaiya, Kenneth A Rivlin, Mary E Sehl, Modupe Idowu, Titilope Fasipe, Batha Tariq, Amanda Gregg, Bianca Bernal, Candice Deler, Duc T Nguyen, Diane Wilkins, Jemimah O Frempong, Kenneth Nobleza, Melanie M Aviles, Noe Gonzalez, Osarenkhoe Iyamu, Siera Gollan, Smirthy Ganesan, Raymona H Lawrence

    Published: 2026-06-01DOI: 10.1093/jscdis/yoag020.025

Volumes

2026 · 1352025 · 832024 · 67

Cunoștințe potrivite muncii dumneavoastră.

De la începutul gratuit și cercetarea bibliografică personală până la Research Suite complet.

Vezi tarifele →

Sunt incluse toate textele integrale ale editorilor?

Nu. Referințele bibliografice, rezumatele și textele integrale sunt conținuturi diferite. Disponibilitatea unui text integral depinde de sursă, de Open Access și de licențele pe care le aveți deja. Un abonament EUVIMED nu înlocuiește drepturile suplimentare ale editorilor.